LAM
L2 Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-22
| Closed | -$582K | – | 229 |
|
|
2023
Q3 | $582K | Sell |
22
-1,531
| -99% | -$40.5M | 0.27% | 83 |
|
|
2023
Q2 | $1.12M | Sell |
1,553
-393
| -20% | -$282K | 0.55% | 55 |
|
|
2023
Q1 | $1.6M | Buy |
1,946
+558
| +40% | +$458K | 0.88% | 33 |
|
|
2022
Q4 | $1M | Hold |
1,388
| – | – | 0.62% | 48 |
|
|
2022
Q3 | $956K | Buy |
1,388
+404
| +41% | +$278K | 0.66% | 50 |
|
|
2022
Q2 | $582K | Buy |
+984
| New | +$582K | 0.42% | 67 |
|